Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients.
Ozcelik M, Korkmaz T, Odabas H, Gemici C, Ercelep O, Yuksel S, Mert AG, Surmeli H, Isik D, Aydin D, Seker M, Mayadagli A, Ozdemir P, Aliustaoglu M, Gumus M. Ozcelik M, et al. Among authors: korkmaz t. Tumour Biol. 2016 Jul;37(7):8901-7. doi: 10.1007/s13277-015-4776-1. Epub 2016 Jan 11. Tumour Biol. 2016. PMID: 26753955
Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis.
Korkmaz T, Seber S, Kefeli U, Sari E, Canhoroz M, Oven B, Yildirim E, Yasar N, Aydin D, Balvan O, Sener N, Yuksel S, Mert A, Polat O, Yumuk F, Kanat O, Gumus M, Turhal NS. Korkmaz T, et al. Clin Transl Oncol. 2013 Jul;15(7):535-40. doi: 10.1007/s12094-012-0960-6. Epub 2012 Nov 10. Clin Transl Oncol. 2013. PMID: 23143955
Primary renal carcinoid: treatment and prognosis.
Korkmaz T, Seber S, Yavuzer D, Gumus M, Turhal NS. Korkmaz T, et al. Crit Rev Oncol Hematol. 2013 Sep;87(3):256-64. doi: 10.1016/j.critrevonc.2013.02.003. Epub 2013 Mar 9. Crit Rev Oncol Hematol. 2013. PMID: 23478151 Review.
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Genestreti G, Tiseo M, Kenmotsu H, Kazushige W, Di Battista M, Cavallo G, Carloni F, Bongiovanni A, Burgio MA, Casanova C, Metro G, Scarpi E, Korkmaz T, Selcuk S, Roopa K, Califano R. Genestreti G, et al. Among authors: korkmaz t. Clin Lung Cancer. 2015 Nov;16(6):e223-8. doi: 10.1016/j.cllc.2015.04.006. Epub 2015 Apr 24. Clin Lung Cancer. 2015. PMID: 25983005
Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer.
Dinc NS, Aydın K, Odabas H, Ercelep O, Tufan G, Seker M, Yasar N, Aydin D, Yuksel S, Mert A, Ozcelik M, Korkmaz T, Yildiz R, Aliustaoglu M, Mayadagli A, Dane F, Gumus M. Dinc NS, et al. Among authors: korkmaz t. Oncol Res Treat. 2016;39(3):130-4. doi: 10.1159/000444272. Epub 2016 Feb 23. Oncol Res Treat. 2016. PMID: 27030981
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.
Esin E, Oksuzoglu B, Bilici A, Cicin I, Kostek O, Kaplan MA, Aksoy S, Aktas BY, Ozdemir O, Alacacioglu A, Cabuk D, Sumbul AT, Sakin A, Paydas S, Yetisir E, Er O, Korkmaz T, Yildirim N, Sakalar T, Demir H, Artac M, Karaagac M, Harputluoglu H, Bilen E, Erdur E, Degirmencioglu S, Aliyev A, Cil T, Olgun P, Basaran G, Gumusay O, Demir A, Tanrikulu E, Yumuk PF, Imamoglu I, Oyan B, Cetin B, Haksoyler V, Karadurmus N, Erturk I, Evrensel T, Yilmaz H, Beypinar I, Kocer M, Pilanci KN, Seker M, Urun Y, Yildirim N, Eren T, Demirci U; Turkish Oncology Group. Esin E, et al. Among authors: korkmaz t. Cancer Chemother Pharmacol. 2019 Jan;83(1):131-143. doi: 10.1007/s00280-018-3712-7. Epub 2018 Oct 30. Cancer Chemother Pharmacol. 2019. PMID: 30377778
75 results